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INTRODUCTION
Among the chemical carcinogens, at least 30 have been proved to be carcinogenic in the
offspring when given to the mother in late pregnancy l). It is likely that such chemicals or their
metabolites pass across the placenta and have carcinogenic effects on fetuses. Takahashi et al.
demonstrated by macroautoradiography that cetain carcinogens and/or their metabolites passed
quickly across the placentas and were transferred to the fetus 2 ,3,4,5,6).
Since first reported by Nakahara et al. 7), 4-nitroquinoline I-oxide (4-NQO) has been known
as a potent carcinogen in experimental animals. Recently Nomura et al. 8) reported that this
chemical is also carcinogenic to mouse fetuses or sucklings when administered to their mothers
during pregnancy or lactation.
The present paper deals with the distribution of 4-NQO and its metabolites demonstrated by
macroautoradiography an adult, pregnant and fetal mice. The relationship is discussed between
the distribution of the carcinogen in the tissues and the susceptibility of the tissues to it.
MATERIALS AND METHODS
Chemicals: 4-NQO 5, 6, 7, 8, 9, IO_14C (32.6 ftCiJmg) was purchased from Daiichi Pure
Chemical Co. This chemical was 96% pure and was used one month after the purity analysis .
.Macroautoradiography: Sixty ftCi of 14C-Iabeled 4-NQO dissolved in 0.6 ml of acetone was
mixed with 1.2 ml of I % gelatine and the acetone was evaporated in vacuum. The final
volume of the solution was 0.8 m!. One tenth ml of the 4-NQO solution (7.5 ftCi and 230 ftg) was
injected intravenously in each pregnant mouse on the 19th or 16th day of gestation. The same
dose of 14C-Iabeled 4-NQO was injected in young adult mice intravenously or subcutaneously.
The treated mice were killed under ether anesthesia 1, 3, 5 or 24 hours later. Fetuses in t.he left
horn were separated from their mother and were frozen in an acetone-dry ice mixture. Mothers
with fetuses in the right horn were frozen whole. Macroautoradiography was carried out
according to the method described previously 2) •
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Adult mice: As shown in Fig. 1, radioactive substances derived from 14C-labeled 4-NQO were
accumulated intensely in the gallbladder and small intestinal tract and reached the cecum one
hour after intravenous administration. They were also accumulated intensely in the lungs,
kidneys and urinary bladder, moderately in the liver~ heart~ muscle, salivary glands and blood and
slightly in the brain. The patterns of distribution were almost the same 5 hours later. However,
radioactive substances appeared in the large intestinal tract and were eliminated gradually from
the organs described above.
Large amounts of radioactive substances were deposited at the injection site even 24 hours
after subcutaneous administration (Fig. 2). They were distributed intensely in the gallbladder,
intestinal tract, urinary bladder and kidneys, moderately in the liver, lungs, blood and muscles
and slightly in the brain.
Pregnant and fetal mice: As shown in Fig. 3, radioactive substances appeared in the placentas
and fetuses. Their concentrations in fetal tissues and placetas were nearly the same as in the
blood of the mother one hour after intravenous administration. Mammary glands were labeled
rather intensely at that time.
Among fetal organs on the 19th day of gestation, the kidneys, urinary bladder and intestinal
tract were labeled intensely (Fig. 4). The brain was labeled slightly, and the other organs were
labeled moderately. On the other hand, radioactivity was detected uniformly in all organs of
fetuses on the 16th day of gestation.
DISCUSSION
Since Takahashi et a1. 2 ) first observed the distribution of 14C-labeled 3-methylcholanthrene
(3-MC) in adult and fetal mice by macroautoradiography, certain carcinogens such as acetyl-
aminofluorene (AAF)3), dimethylaminoazobenzene (DAB)3), benzo(a)pyrene (BP)4), N-methyl-
N'-nitro-N-nitosoguanidine (MNNG)5) and dimethylnitrosamine (DMN)6) have been examined.
Among them, radioactivity derived from 3-MC and BP was distributed selectively in the excretory
organs of adult mice and fetuses near term. On the other hand, radioactivity derived from DMN
and MNNG was distributed rather uniformly in all organs. The distribution patterns of AAF
and DAB appeared intermediate. These differences may be attributahle to their solubilities in
water. The distribution of 14C-labeled 4-NQO observed herein was similar to that of 3-MC
and BP.
When 4-NQO was administered transplacentally to fetuses, tumors were observed in the
lungs, liver and some other organs 8 ). But these organs were not labeled intensely on the macro-
autoradiograms. So a direct relationship was not observed between the concentration of
radioactivity and the susceptibility to the carcinogen. It may be noteworthy that we can get
information on the total radioactivity of intact 4-NQO and its metabolites, but that information
about its metabolites or binding forms to macromolucules cannot be obtained by macroautoradio-
graphy. 4-NQO is considered to be metabolized to an active form, which is 4-hydroxyamino-
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Macroautoradiograms of sagittal sections of mice given 14C-Iabeled 4-NQO.
Fig. 1, One hour after intravenous administration.
Fig. 2, Twenty four hours after subcutaneous administration.
Fig. 3, One hour after intravenous administration in a pregnant mouse on the
19th day of gestation.
Fig. 4, Fetal mouse removed from the mother shown in Fig. 3. Two different
dimensions of the same fetus.
quinoline I-oxide, to interact with cell components9 ). So further studies are required on individu-
al metabolites in fetal organs to establish a direct relationship.
In any case, 4-NQO or its metabolites pass across the placenta rather easily. Thus one may
consider that active forms of 4-NQO pass across the placenta or that fetuses have an ability to
convert 4-NQO to its active forms. As shown in a previous paper10), the fetus near term has an
ability to metabolize 3-MC. It was shown herein that the radioactive substances derived from
4-NQO were eliminated from the excretory organs in the fetuses, following the mode of metabolism
in adult mice. We therefore assume that 4-NQO is changed to an active form in fetal as well as
in adult mouse tissues.
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Abbreviations: Br, brain; C, cecum; E, eye Imll; F, fetus; G, gallbladder; H, heart;
Inj, injection site; Kid, kidney; Lg, lung; Liv, liver; 1\1, mammary glands; PI, plac-
enta; SI, small intestine; Sp, spleen; St, stomach; C, urinary bladder.
SUMMARY
The distribution of radioactivity from 14C-Iabeled 4-nitroquinoline I-oxide (4-~QO), which
IS a known transplacental carcinogen, was observed by macroautoradiography in adult and
pregnant mice. Radioactive substances derived from the labeled carcinogen passed across the
placenta and were distributed intensely in the kidneys, urinary hIadder and intestinal tract of the
fetus near term and uniformly in all organs of the fetus on the 16th day of gestation. This
indicates that fetus near term has an ability to metabolize this carcinogen. No significant differ-
ences in specific radioactivity was noted between tissues that were susceptible or resistant to this
carcInogen.
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